Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 984 entries
View as:

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01909934 Org: User:
Start: 01/30/14 End: 08/29/24 Due: 08/29/25

Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)

Phase: N/A Priority: Normal
NCT ID: NCT01582854 Org: User:
Start: 06/30/12 End: 11/30/14 Due: 11/30/15

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00328627 Org: User:
Start: 05/31/06 End: 03/31/08 Due: 03/31/09

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06980480 Org: User:
Start: 08/01/25 End: 09/11/28 Due: 09/11/29

Instanyl® Non-Interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT01045603 Org: User:
Start: 12/31/09 End: 04/30/12 Due: 04/30/13

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Phase: N/A Priority: Normal
NCT ID: NCT06798012 Org: User:
Start: 05/14/25 End: 06/08/28 Due: 06/08/29

A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain

Phase: N/A Priority: Normal
NCT ID: NCT05755568 Org: User:
Start: 11/30/23 End: 07/01/24 Due: 07/01/25

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06254950 Org: User:
Start: 03/29/24 End: 08/04/27 Due: 08/04/28

A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland

Phase: N/A Priority: Normal
NCT ID: NCT05147181 Org: User:
Start: 03/11/22 End: 03/28/26 Due: 03/28/27

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00286442 Org: User:
Start: 03/31/06 End: 06/30/07 Due: 06/30/08

A Survey of Icatibant in Pediatric Participants with Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT05509569 Org: User:
Start: 08/24/22 End: 10/31/25 Due: 10/31/26

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00762359 Org: User:
Start: 05/31/07 End: 11/30/08 Due: 11/30/09

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT03439293 Org: User:
Start: 03/13/18 End: 06/26/23 Due: 06/26/24

Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01309828 Org: User:
Start: 03/31/11 End: 10/31/12 Due: 10/31/13

Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01452776 Org: User:
Start: 09/30/11 End: 07/31/13 Due: 07/31/14

Safety of Ramelteon in Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00568789 Org: User:
Start: 06/30/06 End: 09/30/06 Due: 09/30/07

A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT06665035 Org: User:
Start: 05/08/25 End: 03/03/30 Due: 03/03/31

A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02788916 Org: User:
Start: 09/25/15 End: 01/12/17 Due: 01/12/18

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

Phase: N/A Priority: Normal
NCT ID: NCT02221284 Org: User:
Start: 06/30/14 End: 06/30/17 Due: 06/30/18

Observational Study in Preterm Neonates Who Are Sufficiently Stable on Non-Invasive Ventilatory Support

Phase: N/A Priority: Normal
NCT ID: NCT01861795 Org: User:
Start: 06/30/13 End: 03/31/14 Due: 03/31/15

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00306384 Org: User:
Start: 03/31/06 End: 11/30/11 Due: 11/30/12

A Study of TAK-079 in People With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT04159805 Org: User:
Start: 01/14/20 End: 07/12/22 Due: 07/12/23

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00362115 Org: User:
Start: 05/31/06 End: 12/31/06 Due: 12/31/07

Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02064907 Org: User:
Start: 02/28/14 End: 04/30/14 Due: 04/30/15

A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04804540 Org: User:
Start: 12/08/21 End: 02/02/24 Due: 02/02/25